Fully Human anti-GPRC5D CAR T-Cell Therapy RD118 Induces Durable Remissions in Relapsed/Refractory Multiple Myeloma.

已取消 20 由不可一世发布于 2025/10/23 16:05:56

DOI:10.1182/blood.2025030559
作者：Mengmeng Pan,Di Wang,Jie Xu,Shiwei Jin,Yan Wang,Yi Tao,Yuanfang Liu,Wanyan Ouyang,Xiangqin Weng,Hongmei Yi,Yu Huang,Xinmei Cao,Shuhua Li,Fuyuan Zhang,Weiping Zhang,Chunrui Li,Jian-Qing Mi
文献类型：期刊论文
补充材料：只需要正文

其它数据库

Abstract：GPRC5D has emerged as a promising therapeutic target in relapsed/refractory multiple myeloma (RRMM), particularly following progression after BCMA-directed CAR T-cell therapies. RD118 is a n

应助信息

2025-10-23

Book学术机器人

2025/10/23 16:05:56 未找到该文献，机器人已退出，请等待人工下载

2025/10/23 16:05:56 Book学术AI机器人收到请求，开始寻找文献

2025/10/23 16:05:56 已向机器人发送请求

2025-10-23

不可一世发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:International Society for Optics and Photonics (SPIE)4-inch Fizeau interferometer transfer function measurement method